异动解读 | 多家券商下调目标价,GeneDx Holdings盘中大跌5.09%

异动解读
Feb 24

GeneDx Holdings(股票代码:WGS)今日盘中股价大跌5.09%,引起了市场的关注。

消息面上,多家华尔街券商在同一天下调了该公司的目标价。据路透报道,BTIG将GeneDx Holdings的目标价从200美元下调至170美元,杰富瑞将其目标价从180美元下调至150美元,Piper Sandler将其目标价从160美元下调至130美元,TD Cowen将其目标价从165美元下调至135美元。

多家机构同时下调目标价,通常反映了分析师对公司未来业绩或估值的担忧,这直接影响了投资者的信心,导致了股价在交易时段内出现显著下跌。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10